ALKEM LABORATORIES Fact Sheet, ALKEM LABORATORIES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Fact Sheet    (ALKE)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of ALKEM LABORATORIES. For more details, see the ALKEM LABORATORIES quarterly results and ALKEM LABORATORIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALKEM LABORATORIES Price History

Price Rs 3,470.7
Mkt Cap Rs m 414,968
Vol '000 5.3
P/E X 23.7
P/CF X 21.9
EPS (TTM) Rs 146.5
% ch % 0.9
No. of shares m 119.57
% ch week % 4.2
% ch 1-mth % -7.8
% ch 12-mth % 24.4
52 week H/L Rs 4,067.7/2,544.3
(As on Dec 2, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALKEM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ALKEM LABORATORIES EQUITY SHARE DATA
High Rs2,2292,4682,2652,7203,150 
Low Rs1,1751,5781,6931,6602,224 
Sales per share (Unadj.) Rs461.9533.8615.3697.9741.4 
Earnings per share (Unadj.) Rs75.753.464.796.1135.3 
Diluted earnings per shareRs75.753.464.796.1135.3 
Cash flow per share (Unadj.) Rs84.165.480.9117.3158.3 
Dividends per share (Unadj.) Rs15.0013.0016.0025.0030.00 
Adj. dividends per shareRs15.0013.0016.0025.0030.00 
Avg Dividend yield %0.90.60.81.11.1 
Book value per share (Unadj.) Rs373.6406.7454.8515.1616.8 
Adj. book value per shareRs373.6406.7454.8515.1616.9 
Shares outstanding (eoy) m119.57119.57119.57119.57119.57 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.73.83.23.13.6 
Avg P/E ratio x22.537.930.622.819.9 
P/CF ratio (eoy) x20.231.024.518.717.0 
Price / Book Value ratio x4.65.04.44.34.4 
Dividend payout %19.824.324.726.022.2 
Avg Mkt Cap Rs m203,473241,880236,619261,868321,244 
No. of employees `000NANANANANA 
Total wages/salary Rs m10,03911,91613,62515,05516,210 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALKEM LABORATORIES INCOME DATA
Net Sales Rs m55,22663,82573,57283,44488,650 
Other income Rs m1,1201,1548771,0422,332 
Total revenues Rs m56,34664,97974,44984,48690,982 
Gross profit Rs m9,99010,08911,14814,73419,424 
Depreciation Rs m1,0121,4301,9322,5282,746 
Interest Rs m452553546651589 
Profit before tax Rs m9,6469,2609,54712,59818,421 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6002,8761,8101,1052,243 
Profit after tax Rs m9,0476,3847,73611,49316,178 
Gross profit margin %18.115.815.217.721.9 
Effective tax rate %6.231.119.08.812.2 
Net profit margin %16.410.010.513.818.2 
ALKEM LABORATORIES BALANCE SHEET DATA
Current assets Rs m29,17140,13242,16155,05769,288 
Current liabilities Rs m16,89723,83322,17532,44636,041 
Net working cap to sales %22.225.527.227.137.5 
Current ratio x1.71.71.91.71.9 
Inventory Days Days7639241820 
Debtors Days Days4762627266 
Net fixed assets Rs m29,54629,96832,84435,07334,825 
Share capital Rs m239239239239239 
"Free" reserves Rs m44,43348,38954,13961,35473,517 
Net worth Rs m44,67348,62854,37861,59373,756 
Long term debt Rs m1,8161,3072,313739343 
Total assets Rs m58,71870,10075,00690,130104,114 
Interest coverage x22.417.718.520.432.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.91.00.90.9 
Return on assets %16.29.911.013.516.1 
Return on equity %20.313.114.218.721.9 
Return on capital %21.719.717.821.325.7 
Exports to sales %15.217.616.619.222.1 
Imports to sales %00000 
Exports (fob) Rs m8,41011,25912,23816,06119,555 
Imports (cif) Rs m00000 
Fx inflow Rs m8,41011,25912,23816,06119,555 
Fx outflow Rs m1,9032,1032,1052,4832,467 
Net fx Rs m6,5079,15610,13313,57817,088 
ALKEM LABORATORIES CASH FLOW
From Operations Rs m 4,711 2,660 7,797 5,851 12,649 
From Investments Rs m -2,859 -3,572 -3,164 -7,414 -9,985 
From Financial Activity Rs m -1,379 846 -3,789 792 -2,718 
Net Cashflow Rs m 396 1 823 -731 -17 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 58.8%
Institution 19.3%
Non-Institution 21.8%
Total 100.0%
Free Float 41.2%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai - 400013
E-MAIL investors@alkem.com/contact@alkem.com WEB www.alkemlabs.com
TEL 022 3982 9999 FAX 022 2495 2955
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
CHM: Mr. Samprada Singh COMP SEC: Mr. Manish Narang YEAR OF INC: 1973 BSE CODE: 539523 FV (Rs): 2 DIV YIELD (%): 0.9

Read: ALKEM LABORATORIES 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   IND SWIFT LA  FORTIS MALAR  ASTRAZENECA PHARMA  KREBS BIOCHEMICALS  FERMENTA BIOTECH  

Compare ALKEM LABORATORIES With:   IND SWIFT LA  FORTIS MALAR  ASTRAZENECA PHARMA  KREBS BIOCHEMICALS  FERMENTA BIOTECH  




Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

ALKEM LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ALKEM LABORATORIES has posted a net profit of Rs 5 bn (up 13.5% YoY). Sales on the other hand came in at Rs 27 bn (up 37.1% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

ALKEM LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ALKEM LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALKEM LABORATORIES. Also includes updates on the valuation of ALKEM LABORATORIES.

ALKEM LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 30.1% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, ALKEM LABORATORIES has posted a net profit of Rs 2 bn (up 30.1% YoY). Sales on the other hand came in at Rs 22 bn (up 7.0% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS